Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Celltrion gets priority review in Canada for Covid-19 drug regdanvimab

pharmaceutical-technologyAugust 03, 2021

Tag: regdanvimab , Canada , COVID-19 , CT-P59

PharmaSources Customer Service